These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
696 related items for PubMed ID: 15795123
41. SIG1459: A novel phytyl-cysteine derived TLR2 modulator with in vitro and clinical anti-acne activity. Fernández JR, Webb C, Rouzard K, Healy J, Tamura M, Voronkov M, Huber KL, Stock JB, Stock M, Gordon JS, Pérez E. Exp Dermatol; 2018 Sep; 27(9):993-999. PubMed ID: 29797368 [Abstract] [Full Text] [Related]
42. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris. Marta Guarna M, Coulson R, Rubinchik E. FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825 [Abstract] [Full Text] [Related]
43. Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease. Hodge G, Hodge S, Han P. Cytometry; 2002 Aug 01; 48(4):209-15. PubMed ID: 12210145 [Abstract] [Full Text] [Related]
44. Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence. Del Rosso J. J Drugs Dermatol; 2008 Feb 01; 7(2 Suppl):s2-7. PubMed ID: 18404864 [Abstract] [Full Text] [Related]
45. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris. Kurokawa I, Nishijima S, Kawabata S. Eur J Dermatol; 1999 Feb 01; 9(1):25-8. PubMed ID: 9920982 [Abstract] [Full Text] [Related]
46. Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771. Jacobs MR, Appelbaum PC. Expert Opin Pharmacother; 2006 Oct 01; 7(14):1957-66. PubMed ID: 17020421 [Abstract] [Full Text] [Related]
47. A comparison of the effect of vitamin A on cytokine secretion by mononuclear cells of preterm newborns and adults. Bessler H, Wyshelesky G, Osovsky M, Prober V, Sirota L. Neonatology; 2007 Oct 01; 91(3):196-202. PubMed ID: 17377406 [Abstract] [Full Text] [Related]
48. Acne and sebaceous gland function. Zouboulis CC. Clin Dermatol; 2004 Oct 01; 22(5):360-6. PubMed ID: 15556719 [Abstract] [Full Text] [Related]
49. [Anti-microbial therapies for acne vulgaris: anti-inflammatory actions of anti-microbial drugs and their effectiveness]. Murata K, Tokura Y. J UOEH; 2007 Mar 01; 29(1):63-71. PubMed ID: 17380730 [Abstract] [Full Text] [Related]
50. [Effect of doxycycline on inflammation-related cytokines and apoptosis in human conjunctival epithelial cells]. Xiao QG, Liu ZG, Zhang M, Zheng JL, Zhang ZH, Luo LH, Chen JQ. Zhonghua Yan Ke Za Zhi; 2005 Sep 01; 41(9):842-6. PubMed ID: 16191354 [Abstract] [Full Text] [Related]
51. Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes. Hino R, Kobayashi M, Mori T, Orimo H, Shimauchi T, Kabashima K, Tokura Y. Br J Dermatol; 2007 May 01; 156(5):830-7. PubMed ID: 17313491 [Abstract] [Full Text] [Related]
52. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream. Plewig G, Holland KT, Nenoff P. Eur J Dermatol; 2006 May 01; 16(1):48-55. PubMed ID: 16436342 [Abstract] [Full Text] [Related]
53. Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Lee SE, Kim JM, Jeong SK, Jeon JE, Yoon HJ, Jeong MK, Lee SH. Arch Dermatol Res; 2010 Dec 01; 302(10):745-56. PubMed ID: 20697725 [Abstract] [Full Text] [Related]
54. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne. Ghosh S, Sinha M, Bhattacharyya A, Sadhasivam S, Megha J, Reddy S, Saini S, Singh H, Kumar D, Kaur SP, Mishra M, Usharani D, Ghosh S, Sengupta S. J Invest Dermatol; 2018 Jun 01; 138(6):1400-1408. PubMed ID: 29409921 [Abstract] [Full Text] [Related]
55. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Jang CH, Choi JH, Byun MS, Jue DM. Rheumatology (Oxford); 2006 Jun 01; 45(6):703-10. PubMed ID: 16418198 [Abstract] [Full Text] [Related]
56. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones. Resh W, Stoughton RB. Arch Dermatol; 1976 Feb 01; 112(2):182-4. PubMed ID: 134675 [Abstract] [Full Text] [Related]
57. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Kim J. Dermatology; 2005 Feb 01; 211(3):193-8. PubMed ID: 16205063 [Abstract] [Full Text] [Related]
58. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory. Jappe U, Boit R, Farrar MD, Ingham E, Sandoe J, Holland KT. J Eur Acad Dermatol Venereol; 2004 Jul 01; 18(4):450-4. PubMed ID: 15196160 [Abstract] [Full Text] [Related]
59. The potential use of Echinacea in acne: control of Propionibacterium acnes growth and inflammation. Sharma M, Schoop R, Suter A, Hudson JB. Phytother Res; 2011 Apr 01; 25(4):517-21. PubMed ID: 20830697 [Abstract] [Full Text] [Related]
60. Interleukin-16 inhibits immunoglobulin e production by B lymphocytes. Trudelle A, El Bassam S, Pinsonneault S, Mazer B, Laberge S. Int Arch Allergy Immunol; 2007 Apr 01; 143(2):109-18. PubMed ID: 17228167 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]